FDA Clearance

In February 2021, we received FDA clearance for the acute and preventive treatment of migraine in adolescents 12 to 17 years of age.

By clicking “Accept” you are agreeing to eletroCore to place cookies on your browser to gather web statistics that help us improve our site experience. Please read our Privacy Policy for more information on the types of cookies we use.